The efficacy and safety of Tipapkinogen Sovacivec therapeutic HPV vaccine in cervical intraepithelial neoplasia grades 2 and 3: Randomized controlled phase II trial with 2.5 years of follow-up-Reference-Cited by-同舟云学术

The efficacy and safety of Tipapkinogen Sovacivec therapeutic HPV vaccine in cervical intraepithelial neoplasia grades 2 and 3: Randomized controlled phase II trial with 2.5 years of follow-up

Published:2019-06 Issue:3 Volume:153 Page:521-529
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Harper Diane M.,Nieminen Pekka,Donders Gilbert,Einstein Mark H.,Garcia Francisco,Huh Warner K.,Stoler Mark H.,Glavini Katerina,Attley Gemma,Limacher Jean-Marc,Bastien Berangere,Calleja Elizabeth

Funder

Roche

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference28 articles.

1. Alvarez RD, Huh WK, Bae S, Lamb LS Jr, Conner MG, Boyer J, et al. A pilot study of pNGVL4a-CRT/E7(detox) for the treatment of patients with HPV16+ cervical intraepithelial neoplasia 2/3 (CIN2/3). Gynecol. Oncol.. 2016 Feb;140(2):245–52. doi:https://doi.org/10.1016/j.ygyno.2015.11.026.

2. Incomplete excision of cervical precancer as a predictor of treatment failure: a systematic review and meta-analysis;Arbyn;Lancet Oncol.,2017

3. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018

4. Regression of high-grade cervical intraepithelial neoplasia with TG4001 targeted immunotherapy;Brun;Am. J. Obstet. Gynecol.,2011

5. Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis;Bruni;Lancet Glob. Health,2016

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating the landscape of HPV-associated cancers: From epidemiology to prevention;Pathology - Research and Practice;2024-11

2. HPV Infections—Classification, Pathogenesis, and Potential New Therapies;International Journal of Molecular Sciences;2024-07-11

3. Comparison of preclinical efficacy of immunotherapies against HPV-induced cancers;Expert Review of Vaccines;2024-07-08

4. Current status and future directions for the development of human papillomavirus vaccines;Frontiers in Immunology;2024-06-25

5. A comprehensive bibliometric analysis (2000–2022) on the mapping of knowledge regarding immunotherapeutic treatments for advanced, recurrent, or metastatic cervical cancer;Frontiers in Pharmacology;2024-05-10